GEIS-52

v. 0.1

20-ABRIL-2017



Phase I-II trial of sunitinib plus nivolumab after standard treatment in advanced soft tissue and bone sarcomas.



Supported browsers:
Chrome v.75 or superior
Firefox v.57 or superior
Other browsers are not supported.